Anavex Life Sciences Corp (AVXL)

[Gator328]

I don't know if there was a buyout offer -- even a meager one -- way back when Biogen was interested in A273 for MS treatment. It's possible. I also highly doubt that Dr. Missling would have been willing to reveal anything to Biogen regarding the Alzheimers trials knowing that they were developing a competing drug candidate.

I do agree with you that if Aducanumab gets pulled from the market or replaced, or if insurance companies refuse to pay for it, Biogen will deeply regret not pursuing Anavex when it had an opportunity to do so -- but I don't think there would have been many offers that Dr. Missling was willing to accept because of his confidence that Sigma-1 was an unturned key in neurological research.